Author Archive: Jeremy Parkinson
Peabody Energy Follow-Up
The lottery ticket on BTU has worked pretty quickly. Prices are all over the place on this near-Chapter 11 bond, but I think the offer has gone up to about 7 1/2. I wrote some calls on BTU equity against the position. The logic in this trade is very strong; if the bonds are worth […]
Oil Is So Much More Than A Commodity
Oil is so much more than a commodity. It’s a force bigger than the $1 trillion market. It’s a weapon, it’s a strategic asset and it’s a curse. Oil can make or break a country, a company, a person. Oil builds fortunes and it makes you poor. And it sets the stage for one of […]
Greenback’s Tone Sours, Sterling May Shine
The reversal of the US dollar’s gains half way through Draghi’s press conference has undermined the near-term technical tone. The risk is on the downside, at least in the first part of the week, ahead of the FOMC meeting. The US Dollar Index posted an outside down session on March 10. It drove the five-day moving […]
Have The Long-Term Trends Improved? You Can Decide
21 Charts In This Week’s Video Video Length – 00:31:35
Gold Daily And Silver Weekly Charts – Central Banks As Financial Cosmeticians
Friday was just one of those days where the ‘invisible hand’ tried to instill some confidence in the wise and benevolent judgement of the money masters, after a central bank, in this case the ECB, does something very visible and ‘lays an egg’ in doing it. So after all this yesterday, are you feeling more […]
Scotts Miracle-Gro – Chart Of The Day
The Chart of the Day belongs to Scotts Miracle-Gro (NYSE: SMG). I found the agricultural chemical stock by using Barchart to sort today’s All Time High list first for the highest number of new highs in the last month, then again for technical buy signals above 80%. Then I used the Flipchart feature to review the stocks. Since the Trend spotter signaled […]
Do These Funds Work? 3 ETFs Facing Uphill Challenges
ETF investors are always searching for unique strategies that offer promises of inflation protection or anti-volatility positioning. These funds are often drawn up using sophisticated back-testing analysis and touted as a strong “alternative” to compliment your existing portfolio of stocks and bonds. However, there are some instances where the strategy either falls flat from the […]
A Defensive Game Plan For This Friendless Market
I’m sure you’ve heard the popular saying… “The trend is your friend.” And also variations of it, like… “The trend is your friend… until it ends.” And my personal favorite… “The trend is your friend… until it stabs you in the back!” The idea here is simple: following along with your friend, the trend, is usually beneficial. […]
Two Charts To Consider Before The Monday Open
Deja-vu all over again… And what happened next? Trade accordingly…
E Sarepta’s Muscle Drug Gets New FDA Review Date
On Thursday shares of Sarepta Therapeutics (SRPT) closed up 15% for the day as the company stated that the FDA had set a new FDA independent panel review date. The original review date for Sarepta’s drug Eteplirsen was set to happen on January 20th. The problem was that a forecast of weather, that week forced […]
